Introduction: Clopidogrel ineffectiveness is a serious problem in antiplatelet therapy. Many factors may contribute to this phenomenon. One of them is clopidogrel drugedrug interaction with CYP2C19 and CYP3A4 enzyme inhibitors. The main goal of this descriptive study was to assess the prevalence of cases of clopidogreledrug interactions in the primary health care physicians' practices. Materials and methods: During 2010e2011, 80 patients receiving clopidogrel antiplatelet therapy from primary care physicians' clinical practices were involved in this study. By using questionnaires and case histories, the following information was collected: Age, gender, clinical diagnoses, and medications used. Results: In the current study, drugs were used ...
<div><p>Objectives</p><p>In 2009, the FDA issued a warning that omeprazole–a proton pump inhibitor (...
ObjectivesThis study sought to evaluate the clinical relevance of potential clopidogrel drug–drug in...
Background— We observed that the prodrug clopidogrel was less effective in inhibiting platelet aggre...
Introduction: Clopidogrel ineffectiveness is a serious problem in antiplatelet therapy. Many factors...
Clopidogrel reduces the cardiovascular risks because of inhibitory action on platelets aggregation b...
Background: Recent studies have suggested that proton pump inhibitors (PPIs) may inhibit the antipla...
AbstractBackgroundClopidogrel, a prodrug is found to be less effective in inhibiting the platelet ag...
Multidrug therapy increases the risk for drug–drug interactions. Clopidogrel, a prodrug, requires he...
Background: Clopidogrel, a prodrug is found to be less effective in inhibiting the platelet aggregat...
Objective: Proton pump inhibitors (PPIs) are known to impair cytochrome P2C19 mediated activation of...
textIntroduction: Proton pump inhibitors (PPI) may impair the biotransformation of clopidogrel leadi...
PURPOSE: Clopidogrel is metabolized by the hepatic cytochrome P450 (CYP) system into its active thio...
WOS: 000374326900124Background & Objectives: Proton Pump Inhibitors (PPIs) are among the most prescr...
OBJECTIVE: To measure the association between use of proton pump inhibitors and a range of harmful o...
Paul A Gurbel1, Udaya S Tantry1, Dean J Kereiakes21Sinai Center for Thrombosis Research, Sinai Hospi...
<div><p>Objectives</p><p>In 2009, the FDA issued a warning that omeprazole–a proton pump inhibitor (...
ObjectivesThis study sought to evaluate the clinical relevance of potential clopidogrel drug–drug in...
Background— We observed that the prodrug clopidogrel was less effective in inhibiting platelet aggre...
Introduction: Clopidogrel ineffectiveness is a serious problem in antiplatelet therapy. Many factors...
Clopidogrel reduces the cardiovascular risks because of inhibitory action on platelets aggregation b...
Background: Recent studies have suggested that proton pump inhibitors (PPIs) may inhibit the antipla...
AbstractBackgroundClopidogrel, a prodrug is found to be less effective in inhibiting the platelet ag...
Multidrug therapy increases the risk for drug–drug interactions. Clopidogrel, a prodrug, requires he...
Background: Clopidogrel, a prodrug is found to be less effective in inhibiting the platelet aggregat...
Objective: Proton pump inhibitors (PPIs) are known to impair cytochrome P2C19 mediated activation of...
textIntroduction: Proton pump inhibitors (PPI) may impair the biotransformation of clopidogrel leadi...
PURPOSE: Clopidogrel is metabolized by the hepatic cytochrome P450 (CYP) system into its active thio...
WOS: 000374326900124Background & Objectives: Proton Pump Inhibitors (PPIs) are among the most prescr...
OBJECTIVE: To measure the association between use of proton pump inhibitors and a range of harmful o...
Paul A Gurbel1, Udaya S Tantry1, Dean J Kereiakes21Sinai Center for Thrombosis Research, Sinai Hospi...
<div><p>Objectives</p><p>In 2009, the FDA issued a warning that omeprazole–a proton pump inhibitor (...
ObjectivesThis study sought to evaluate the clinical relevance of potential clopidogrel drug–drug in...
Background— We observed that the prodrug clopidogrel was less effective in inhibiting platelet aggre...